<DOC>
	<DOCNO>NCT02850783</DOCNO>
	<brief_summary>Rationale : Lymph node status important factor selection patient adjuvant chemotherapy surgical treatment primary colorectal carcinoma . Up 30 % stage I/II patient negative lymph node involvement develop distant metastasis eventually die colorectal carcinoma ( CRC ) . Better detection pathologic stag lymph node could contribute good survival colon cancer patient . This sentinel lymph node ( SLN ) procedure aim identify first drain lymph node ( ) primary tumour , high risk harbouring metastasis . These SLNs pathological analyse several sensitive histopathologic technique like immunohistochemical staining ( IHC ) . Objective : Aim study investigate combination radioactive fluorescent tracer increase sensitivity specificity sentinel lymph node mapping ( SLNM ) technique colon cancer utilize radioactive component preoperative imaging ( PET/CT ) SLNs near infrared ( NIR ) fluorescence component guidance SLNs surgery . Study design : Single centre pilot study Study population : Ten patient colon cancer ( colon ascendens , colon transversum , colon descendens , sigmoid ) stage Tis-T1-T2-T3 , schedule laparoscopic surgical resection tumour . Intervention ( applicable ) : The present study perform radioactive tracer 89Zr-Nanocoll fluorescent tracer Indocyanine Green ( ICG ) . A colonoscopy perform inject radioactive tracer 48 hr surgery . After injection , patient undergo first PET/CT scan . A second PET/CT scan perform ± 24 hrs tracer injection third scan surgical procedure ; ± 48 hr tracer administration . During surgical procedure ICG dilute saline human albumin inject base tumour colonoscopy . The PET/CT image compare respect total number location focus , visible , lymphatic vessel . During surgery fluorescent node mark suture vivo . Thereafter PET/CT image use roadmap , detect SLNs visible NIR laparoscope . These node mark suture . When radioactive and/ fluorescent node detect , specimen resect like conventional method . Ex vivo specimen inspect fluorescent and/or radioactive node find vivo . All identify node take ex vivo store separately . The entire specimen submit pathologic examination . All identify SLNs stain hematoxylin-eosin ( H &amp; E ) . If fluorescent radioactive SLNs negative routine H &amp; E staining , slice multiple part examine H &amp; E stain immunohistochemistry specific marker CAM5.2 . Finally , pathologist us palpation identify remain non-fluorescent and/ radioactive lymph node . Nodes find palpation screen fluorescent and/ radioactive activity . The amount tumour tissue positive node evaluate Q-prodit ; interactive video morphometry system ( Leica , Cambridge , UK ) . Main study parameters/endpoints : Main study parameter identification rate SLN mapping preoperative PET/CT scan combine intraoperative near-infrared ( NIR ) fluorescence image patient colon carcinoma . Thereby biodistribution kinetics 89Zr-Nanocoll consider primary study parameter . Secondary endpoint number localization SLNs optimal tracer volume . Nature extent burden risk associate participation , benefit group relatedness : All participate patient receive conventional resection tumour follow-up accord normal standard hospital . The main goal study optimize SLN map technique colon cancer . If investigator able identify true SLN could lead good stag survival patient type cancer . . Because colonoscopy ± 48 hr surgery , patient stay hospital prolong one day . The additional risk exposure radiation participate patient calculate consider negligible .</brief_summary>
	<brief_title>SLN Colon Cancer Using Multimodal Tracer</brief_title>
	<detailed_description />
	<mesh_term>Colonic Neoplasms</mesh_term>
	<criteria>Oral write informed consent Age 18 year old Colon cancer ( TisT1T2T3 ) Laparoscopic surgical resection tumour Regular preoperative workup Patients young 18 year Patients legally mentally incapable unable give inform consent Gross lymph node involvement Invasion tumour surround tissue Distant metastases T4 metastatic disease discover intraoperative staging Contraindications laparoscopic surgery Patients high risk anaphylactic reaction Pregnancy Recent myocardial infarction Allergy iodine Claustrophobia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>colon cancer</keyword>
</DOC>